Background Fever occurring in a neutropenic patient remains a common life‐threatening
complication of cancer chemotherapy. The common practice is to admit the patient to …

Context: Neutropenia is one of the grave consequences of cancer chemotherapy, and the
treatment of neutropenic febrile patients with intravenous (iv) antibiotics has been shown to …

Background People with febrile neutropaenia are usually treated in a hospital setting.
Recently, treatment with oral antibiotics has been proven to be as effective as intravenous …

Background The pattern of infections among neutropenic cancer patients has shifted in the
last decades to a predominance of Gram‐positive infections. Some of these Gram‐positive …

Background People with cancer with febrile neutropenia are at risk of severe infections and
mortality and are thus treated empirically with broad‐spectrum antibiotic therapy. However …

Background Febrile neutropenia is a frequent adverse event experienced by people with
cancer who are undergoing chemotherapy, and is a potentially life‐threatening situation …

Background The pattern of infections among neutropenic patients with cancer has shifted in
the last decades to a predominance of gram‐positive infections. Some of these gram …

Background Among patients with fever and neutropenia during cancer chemotherapy who
have a low risk of complications, oral administration of empirical broad-spectrum antibiotics …

Background Continued controversy surrounds the optimal empirical treatment for febrile
neutropenia. New broad‐spectrum beta‐lactams have been introduced as single treatment …

Background In some centers, outpatient management for cancer patients with low-risk febrile
neutropenia (FN) has been implemented into routine clinical practice. Our objective was to …